Application of metrnl in prevention and treatment of ulcerative colitis
A potential technology for ulcerative colitis, applied in the field of molecular biology and biomedicine, to achieve the effect of small side effects and high safety
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0037] 1. Method
[0038] 1. Animals: Metrnl intestinal epithelial-specific knockout mice and corresponding control wild-type mice were used, with 9 to 12 mice in each group. For the breeding methods of these mice, please refer to the applied patent (application number 201610458874.0) and published Literature (ActaPharmacol Sin. 2016 Aug 22. doi:10.1038 / aps. 2016. 70. [Epub ahead of print]).
[0039] 2. Administration of dextran sulfate sodium (DSS): DSS (molecular weight 36,000-50,000) from MP Company was used to prepare a 3% concentration and administered by free drinking to prepare a DSS-induced ulcerative colitis model .
[0040]3. Overall index detection: body weight is measured at 10 o'clock in the morning every day, and the weight change is scored (0 points for weight gain and change within 1%, 1 point for change of 1%-5%, 1 point for change of 5% -10% is 2 points, a change of 10%-15% is 3 points, and a change of more than 15% is 4 points); observe the mouse feces and...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com